Unknown

Dataset Information

A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre.


ABSTRACT:

Aims

We aimed to detail the early clinical experience with pVAD 5.5 at a large academic medical centre. Impella® 5.5 (Abiomed) is a temporary peripherally inserted left ventricular assist device (pVAD) used for the treatment of cardiogenic shock (CS). This system has several modifications aimed at improving deliverability and durability over the pVAD 5.0 system, but real-world experience with this device remains limited.

Methods and results

We collected clinical and outcome data on all patients supported with pVAD 5.5 at our centre between February and December 2020, including procedural and device-related complications. Fourteen patients with pVAD 5.5 were included. Aetiology of CS was acute myocardial infarction (n = 6), decompensated heart failure (n = 6), suspected myoca

SUBMITTER: Kennel PJ 

PROVIDER: S-EPMC8497328 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature